TTRX Turn Therapeutics Inc. logo

TTRX Turn Therapeutics Inc.

Healthcare
$5.13+3.22%ClosedMarket Cap: $152.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

24.72

P/S

0.00

EV/EBITDA

-22.10

DCF Value

$0.18

FCF Yield

-2.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-116.8%

ROA

-20.6%

ROIC

-49.6%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$-971.0K$
Q4 null$0.00$279.1K$
FY null$0.00$-3.2M$
Q3 null$0.00$-1.9M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
D. Boral CapitalBuy
2026-03-24
D. Boral CapitalBuy
2026-01-20

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

1.89

Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.

Peers